Connect with us

Health

Recipients testing positive in Israel sparks concern over Pfizer vaccine efficacy – Global Times

More than 12,400 in Israel were reportedly infected after accepting Pfizer’s COVID-19 vaccine, which led to doubts over the vaccine’s efficacy, despite the reported…

Published

on

post featured image

An illustration shows vials of a COVID-19 vaccine and syringes with the logos of US pharmaceutical company Pfizer and German partner BioNTech. Photo: AFP
More than 12,400 in Israel were reportedly infected after accepting Pfizer’s COVID-19 vaccine, which led to doubts over the vaccine’s efficacy, despite the reported 95 percent efficacy in Phase III clinical trials.  
This can be a sign that the vaccine’s efficacy is not necessarily the same as data from experiments, which is affected by many elements…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending